FDA inspection
Anika Therapeutics, Inc.: FDA inspection ending Apr 13, 2026
FDA inspection 1305600 · No Action Indicated (NAI) · Bedford, MA
Key facts
| Inspection ID | 1305600 |
|---|---|
| Firm | Anika Therapeutics, Inc. |
| FEI number | 3007093114 |
| Address | 32 Wiggins Ave |
| City | Bedford |
| State | MA |
| ZIP | 01730 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Apr 13, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data